Black Rock Inc. Vir Biotechnology, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 16,434,122 shares of VIR stock, worth $122 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,434,122

Previous 16,563,612 0.78%

Holding current value

$122 Million

Previous $168 Million 12.83%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.63 - $12.66 $988,008 - $1.64 Million	-129,490 Reduced 0.78%	16,434,122 $146 Million
Q1 2024 May 10, 2024	SELL	$8.6 - $11.9 $2.59 Million - $3.58 Million	-300,967 Reduced 1.78%	16,563,612 $168 Million
Q4 2023 Feb 13, 2024	BUY	$7.76 - $10.29 $8.23 Million - $10.9 Million	1,060,666 Added 6.71%	16,864,579 $170 Million
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $16.7 Million - $45 Million	1,828,956 Added 13.09%	15,803,913 $148 Million
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $451,611 - $531,227	19,466 Added 0.14%	13,974,957 $343 Million
Q1 2023 May 12, 2023	SELL	$22.26 - $30.85 $4.03 Million - $5.59 Million	-181,137 Reduced 1.28%	13,955,491 $325 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $5.25 Million - $7.42 Million	262,902 Added 1.89%	14,136,628 $358 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $19.4 Million - $33 Million	1,062,036 Added 8.29%	13,873,726 $267 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $141 Million - $198 Million	7,415,506 Added 137.42%	12,811,690 $326 Million
Q1 2022 May 12, 2022	BUY	$21.19 - $40.01 $1.87 Million - $3.53 Million	88,135 Added 1.66%	5,396,184 $139 Million
Q4 2021 Feb 10, 2022	BUY	$30.97 - $54.03 $4.6 Million - $8.02 Million	148,420 Added 2.88%	5,308,049 $222 Million
Q3 2021 Nov 09, 2021	BUY	$34.9 - $54.54 $6.21 Million - $9.71 Million	177,991 Added 3.57%	5,159,629 $225 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $193 Million - $254 Million	4,981,638 New	4,981,638 $236 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account